Trial intelligence / Profile preview

Phase 2 intra-articular DE-098 in rheumatoid arthritis

jRCT2080221430Phase 2

Sponsor
Santen Pharmaceutical
Start
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing DE-098 with Placebo (2 arms).

02

Drugs

dexamethasone palmitate
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on jRCT2080221430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call